ARO-ENaC
AROENaC1001
Phase 2 small_molecule terminated
Quick answer
ARO-ENaC for Cystic Fibrosis, Pulmonary is a Phase 2 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arrowhead Pharmaceuticals Ireland Limited
- Indication
- Cystic Fibrosis, Pulmonary
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated